Hypertension is still the number one global killer. No matter what causes are, lowering blood
pressure can significantly reduce cardiovascular complications, cardiovascular death, and …

For most patients with systemic hypertension, long-term drug treatment is indicated and is
beneficial. There is overwhelming evidence to suggest that antihypertensive drugs offer …

Approximately 65 million individuals in the United States suffer from systemic hypertension.
Hypertension leads to various cardiovascular diseases including myocardial infarction …

Hypertension is a key risk factor for cardiovascular disease. Current management of
hypertension, both pharmacologic and nonpharmacologic, is based on an extensive amount …

Hypertension is one of the leading causes of disability-adjusted life years and mortality, with
approximately 15% prevalence worldwide. Most patients with hypertension from low-to high …

Despite the many outstanding favorable results achieved in the treatment of hypertension,
several unmet goals of antihypertensive therapy remain, such as better blood pressure …

Hypertension remains a major risk factor for cardiovascular disease. The optimal choice of
pharmacologic and nonpharmacologic treatment regimens is based on a plethora of …

Hypertension is the most prevalent and significant modifiable risk factor in individuals with
concomitant coronary artery disease. The number of individuals with hypertension is …

When treating hypertension, physicians now have a huge range of drugs from which to
choose in formulating a management strategy. This accessible guide helps the busy …

Epidemiological studies suggest a strong association between hypertension and ischemic
heart disease (IHD), and hypertension is a major independent risk factor for the …